Page last updated: 2024-09-04

ezetimibe and ro 48-8071

ezetimibe has been researched along with ro 48-8071 in 1 studies

Compound Research Comparison

Studies
(ezetimibe)
Trials
(ezetimibe)
Recent Studies (post-2010)
(ezetimibe)
Studies
(ro 48-8071)
Trials
(ro 48-8071)
Recent Studies (post-2010) (ro 48-8071)
2,4845631,46532014

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)ro 48-8071 (IC50)
Squalene--hopene cyclaseAlicyclobacillus acidocaldarius subsp. acidocaldarius DSM 4460.06
Lanosterol synthaseHomo sapiens (human)0.0793
Fatty-acid amide hydrolase 1Rattus norvegicus (Norway rat)0.0065
Monoglyceride lipaseRattus norvegicus (Norway rat)0.0065

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chuang, JC; Lopez, AM; Posey, KS; Repa, JJ; Turley, SD; Valasek, MA1

Other Studies

1 other study(ies) available for ezetimibe and ro 48-8071

ArticleYear
Sustained and selective suppression of intestinal cholesterol synthesis by Ro 48-8071, an inhibitor of 2,3-oxidosqualene:lanosterol cyclase, in the BALB/c mouse.
    Biochemical pharmacology, 2014, Apr-01, Volume: 88, Issue:3

    Topics: Animals; Azetidines; Benzophenones; Cholesterol; Diet; Ezetimibe; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intestinal Mucosa; Intestine, Small; Intramolecular Transferases; Liver; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Receptors, LDL; Simvastatin; Species Specificity

2014